Protalix BioTherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 957 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 251-275 of 671 matching filings.

Per page
25
Current page
11
4

OWNERSHIP DOCUMENT

Filing date
22 Jan 2020
Reporting date
20 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Jan 2020
Reporting date
20 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Jan 2020
Reporting date
20 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Jan 2020
Reporting date
20 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Jan 2020
Reporting date
20 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
03 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
03 Jan 2020
Reporting date
01 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
20 Dec 2019
Reporting date
19 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
19 Dec 2019
Reporting date
17 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33357

CT ORDER filing

Filing date
17 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
09 Dec 2019
Reporting date
09 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33357

DEFA14A

Filing date
26 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
18 Nov 2019
Reporting date
18 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33357

DEFA14A

Filing date
15 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33357

DEFA14A

Filing date
12 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
07 Nov 2019
Reporting date
07 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
17 Oct 2019
Reporting date
17 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEF 14A

Filing date
15 Oct 2019
Reporting date
09 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33357

PRE 14A

Filing date
04 Oct 2019
Reporting date
09 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
24 Sep 2019
Reporting date
22 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
24 Sep 2019
Reporting date
22 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K

Filing date
24 Sep 2019
Reporting date
24 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
30 Aug 2019
Reporting date
26 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
13 Aug 2019
Reporting date
13 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .